New talent joining the team!!
We are very happy to announce that Monika is joining the HiTT Foundation. She brings a solid scientific and drug discovery career, enthusiasm and capacity
We are very happy to announce that Monika is joining the HiTT Foundation. She brings a solid scientific and drug discovery career, enthusiasm and capacity
Fundació HiTT (FHiTT) is developing a new targeted therapy to treat aggressive cancers. This treatment, unlike the current highly toxic and unspecific options available, will offer increased efficacy and reduce side-effects, enhancing the life expectancy and well-being of cancer patients.